Get started
Author

Tatjana Walther

Observed names: T Walther, T. Walther, Walther, Tatjana
OpenAlex ID: A5081960245
Accurate and efficient detection of gene fusions from RNA sequencing data
2021 · Sebastian Uhrig, Julia Ellermann, et al. · Genome Research · 523
PDF
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib
2016 · Sascha Dietrich, Andreas Pircher, et al. · Blood · 131
PDF
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations
2017 · Benjamin H. Durham, Bartlomiej Getta, et al. · Blood · 115
Drug-perturbation-based stratification of blood cancer
2017 · Dietrich, Sascha, Oleś, Małgorzata, et al. · Kölner Universitäts PublikationsServer (Universität zu Köln) · 109
PDF
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia
2018 · Alexander C. Leeksma, Justin Taylor, et al. · Leukemia · 48
PDF
MED 12 mutations and NOTCH signalling in chronic lymphocytic leukaemia
2017 · Bian Wu, Mikołaj Słabicki, et al. · British Journal of Haematology · 41
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions
2024 · Julia Schöpf, Sebastian Uhrig, et al. · Nature Communications · 34
PDF
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma
2018 · Alexander Jethwa, Mikołaj Słabicki, et al. · Blood · 33
PDF
Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity
2019 · Junyan Lu, Martin Böttcher, et al. · Haematologica · 31
PDF
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma
2018 · K. Tomska, R. Kurilov, et al. · Scientific Reports · 28
PDF
Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies
2020 · Marina Lukas, Britta Velten, et al. · Leukemia · 23
PDF
Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia
2023 · Almut Lütge, Junyan Lu, et al. · Haematologica · 16
PDF
Dissection of CD20 regulation in lymphoma using RNAi
2016 · M Słabicki, K S Lee, et al. · Leukemia · 16
Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia
2021 · Almut Lütge, Junyan Lu, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening
2025 · Marcel Fabian Pohly, Kerstin Putzker, et al. · Blood · 2
114 | Systematic Investigation of Disease‐ and Genotype‐specific Vulnerabilities in Primary Blood Cancer Using High‐throughput Ex Vivo Drug Screening
2025 · K. D. Hofer, S. Scheinost, et al. · Hematological Oncology
PDF
Abstract 2904: Synthetic lethal relationship between pharmacologic PARP inhibition and loss of LIG1 in chordoma
2025 · Kwang Seok Lee, Tatjana Walther, et al. · Cancer Research
Abstract 4544: Genomic, transcriptomic, functional, and mechanistic characterization of rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusions
2023 · Julia Schoepf, Sebastian Uhrig, et al. · Cancer Research
The Landscape of Drug Perturbation Effects in Leukemia and Lymphoma
2019 · S. Scheinost, J. Lu, et al. · Hematological Oncology
Rare Coding Variants in the Mme Gene, Encoding the Metalloprotease Neprilysin, Are Linked to Late-onset Axonal Neuropathies
2016 · Michaela Auer‐Grumbach, David Bennett, et al. · City Research Online (City University London)
Works count: 21
Citation count: 1,152
H-index: 13
I10-index: 13
Year
Topic
Type